Vaxxas biomedical expertise to boost Griffith microtech

Queensland Biotechnology startup, Vaxxas has formed a new partnership with Queensland Micro and Nanotechnology Centre (QMNC) at Griffith University to help boost nanotechnology commercialisation.

Vaxxas hold patents over one of the world most exciting biotechnology products, the Nanopatch™, which is a safer, more reliable and durable delivery system for vaccines than needles. QMNC is one of Queensland’s most advanced laboratories, previously focussing on new technologies in energy storage and distribution.

Read the full story here.

Comment

No comments.

Leave a Reply

Your email address will not be published.